ClinicalTrials.Veeva

Menu

Effects of Reverse Natural Apophyseal Glides as Compared to Ventro-cranial Translatoric Glides in the Management of Upper Thoracic Spine Hypomobility.

F

Foundation University Islamabad

Status

Enrolling

Conditions

Upper Thoracic Spine Hypomobility

Treatments

Procedure: Grade III Ventro-Cranial Translatoric Glides(standard protocol)
Procedure: Reverse NAGS(experimental)

Study type

Interventional

Funder types

Other

Identifiers

NCT07006402
FUI/CTR/2024/78

Details and patient eligibility

About

This study is a randomized controlled trial and the purpose of the study is to determine the effects of reverse NAGs as compared to Ventro-cranial Translatoric Glides in upper thoracic spine hypomobility in terms of pain and range of motion.

Full description

OBJECTIVES:

The objectives of this study are :

  1. To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on UPPER BACK PAIN in upper thoracic spine hypomobility.
  2. To determine the effects of reverse NAGs as compared to ventrocranial translatoric glide on THORACIC ROM in upper thoracic spine hypomobility.

HYPOTHESIS:

Alternate Hypothesis:

  1. There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p<0.05).
  2. There will be a statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p<0.05).

NULL HYPOTHSIS :

  1. There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of upper back pain in persons with upper thoracic hypo mobility (p>0.05).
  2. There will be no statistically significant difference in the effects of reverse NAGs as compared to ventrocranial translatoric glides in terms of thoracic ROM in persons with upper thoracic hypo mobility (p>0.05).

RESEARCH DESIGN : Experimental study .Randomized control trail.

Enrollment

48 estimated patients

Sex

All

Ages

18 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Both male and females 2. Adults (18-39 years) 3. Upper Thoracic hypomobility (flexion <20° or extension <25° or side bending <20° or rotation <35°)

Exclusion criteria

  • 1-Ankylosing spondylitis 2-History of Spinal Fusion or spinal surgery (discectomy/laminectomy etc.) 3-Degenerative disc disorders 4-Cervical radiculopathy, Scoliosis 5-Spinal Stenosis or Myelopathy 6-Recent fracture or surgery 7-TB of spine, Spondylolisthesis 8-Not able to attend regular therapy appointments 9-Fibromyalgia/myofascial pain syndrome

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

48 participants in 2 patient groups

Interventional Group
Experimental group
Description:
Study Group (A): 3-4 treatment sessions per week (for 2 weeks) 1. TENS and Hot pack for 20 minutes. 2. Reverse NAGs at level T1-T4 In these type of mobilization, the inferior facet glides up on the superior. The mobilizations are repeated \<6 times and then movements are reassessed. If no change occurs, the process will be repeated upto 10 minutes with resting period.
Treatment:
Procedure: Reverse NAGS(experimental)
Control
Active Comparator group
Description:
Control Group (B): 3-4 treatment sessions per week (for 2 weeks) 1. TENS and Hot pack for 20 minutes. 2. Grade III Ventro-Cranial Translatoric Glides at level T1-T4 The mobilization will be applied and sustained for 30-40 seconds and will be continued for 10-15 minutes in a cyclic manner.
Treatment:
Procedure: Grade III Ventro-Cranial Translatoric Glides(standard protocol)

Trial contacts and locations

1

Loading...

Central trial contact

Anam Shabbir, DPT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems